Atalaya Capital Management LP 13D/13G Filings for AEON Biopharma, Inc. (AEON)

Atalaya Capital Management LP 13D and 13G filings for AEON Biopharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2023-07-31
4:15 pm
Purchase
2023-07-2713GAEON Biopharma, Inc.
AEON
Atalaya Capital Management LP3,675,000
9.890%
3,675,000increase
(New Position)
Filing